Back to Search
Start Over
Oral Presentations.
- Source :
-
Pediatric Dermatology . May2023 Supplement 1, Vol. 40, p4-9. 6p. - Publication Year :
- 2023
-
Abstract
- PCR and culture turned negative simultaneously on systemic therapy except for 2 patients (15%), where PCR turned negative 4 weeks after culture without continued systemic therapy. To our knowledge, this is the first description of topical 5-fluorouracil being used as an effective treatment for trichodysplasia spinulosa and, pending confirmation, may represent a more cost-effective and widely available treatment than topical cidofivir. Efficacy and safety of dupilumab treatment up to 1 year in infants and preschool children wit... Michael J. Cork 1, Amy S. Paller 2,3, Elaine C. Siegfried 4,5, Jing Xiao 6, Randy Prescil... 1 Sheffield Dermatology Research, University of Sheffield Sheffield Children's Hospital, Shef... B Objectives: b To report dupilumab efficacy and safety in children aged from 6 months to 5 years with moderate-to-severe atopic dermatitis (AD) treated for up to 1 year. B Discussion: b Dupilumab treatment for 1 year provides sustained improvement in signs of AD and quality of life with an acceptable safety profile in patients aged from 6 months to 5 years with moderate-to-severe AD. [Extracted from the article]
Details
- Language :
- English
- ISSN :
- 07368046
- Volume :
- 40
- Database :
- Academic Search Index
- Journal :
- Pediatric Dermatology
- Publication Type :
- Academic Journal
- Accession number :
- 163283734
- Full Text :
- https://doi.org/10.1111/pde.15300